8.31
price up icon1.59%   0.13
after-market 시간 외 거래: 8.50 0.19 +2.29%
loading

Intellia Therapeutics Inc 주식(NTLA)의 최신 뉴스

pulisher
03:39 AM

Cathie Wood's Ark Invest Loads Up On Intellia Therapeutics, Offloads Meta Platforms - Benzinga

03:39 AM
pulisher
Apr 25, 2025

Cathie Wood’s ARK offloads Meta, boosts Intellia stock - Investing.com Australia

Apr 25, 2025
pulisher
Apr 25, 2025

Cathie Wood’s ARK offloads Meta, boosts Intellia stock By Investing.com - Investing.com South Africa

Apr 25, 2025
pulisher
Apr 25, 2025

Is Intellia Therapeutics Inc (NASDAQ:NTLA) A Better Buy Than Others After A -62.53% Fall In This Year? - Marketing Sentinel

Apr 25, 2025
pulisher
Apr 23, 2025

Insider Sale Alert: Intellia Therapeutics Inc [NTLA] – Is it Time to sell? - knoxdaily.com

Apr 23, 2025
pulisher
Apr 23, 2025

Lawsuit for Investors in shares of Intellia Therapeutics, Inc. (NASDAQ: NTLA) announced by the Shareholders Foundation - PR Newswire

Apr 23, 2025
pulisher
Apr 21, 2025

Wolfe Research Upgrades Intellia Therapeutics (NTLA) - Nasdaq

Apr 21, 2025
pulisher
Apr 21, 2025

Intellia Therapeutics shares up after Wolfe upgrade - MSN

Apr 21, 2025
pulisher
Apr 21, 2025

Intellia Therapeutics Shares Rise After Upgrade From Wolfe Research - marketscreener.com

Apr 21, 2025
pulisher
Apr 21, 2025

Intellia Therapeutics (NTLA) Surges After Upgrade from Wolfe Research - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

NTLA’s price-to-free cash flow ratio: What it means for investors - uspostnews.com

Apr 21, 2025
pulisher
Apr 21, 2025

Intellia Therapeutics (NTLA) Advances Nex-z in Phase III Trial for ATTRv-PN - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Intellia Therapeutics (NTLA) Eyes Growth with Gene Editing Advances - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Intellia Therapeutics (NTLA) Receives Upgrade to Outperform from Wolfe Research | NTLA Stock News - GuruFocus

Apr 21, 2025
pulisher
Apr 21, 2025

Wolverine World Wide, Pacira BioSciences And Other Big Stocks Moving Higher On Monday - Benzinga

Apr 21, 2025
pulisher
Apr 21, 2025

New Horizons in Biomedical CRISPR Gene Editing Market Exploring - openPR.com

Apr 21, 2025
pulisher
Apr 21, 2025

Wolfe Research Upgrades Intellia Therapeutics to Outperform From Peer Perform, Price Target is $21 - marketscreener.com

Apr 21, 2025
pulisher
Apr 18, 2025

How the (NTLA) price action is used to our Advantage - news.stocktradersdaily.com

Apr 18, 2025
pulisher
Apr 15, 2025

Intellia Therapeutics, Inc. Sued for Securities Law Violations – Investors Should Contact The ... - Bluefield Daily Telegraph

Apr 15, 2025
pulisher
Apr 15, 2025

Intellia Therapeutics, Inc. Sued for Securities Law - GlobeNewswire

Apr 15, 2025
pulisher
Apr 14, 2025

Final Deadline Today for the Intellia Therapeutics, Inc. Securit - GuruFocus

Apr 14, 2025
pulisher
Apr 14, 2025

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Intellia Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesNTLA - PR Newswire

Apr 14, 2025
pulisher
Apr 14, 2025

NTLA INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC - GlobeNewswire

Apr 14, 2025
pulisher
Apr 14, 2025

NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - Business Wire

Apr 14, 2025
pulisher
Apr 14, 2025

Final Deadline Today for the Intellia Therapeutics, Inc. Securities LawsuitContact the DJS Law Group to Discuss Your RightsNTLA - The Malaysian Reserve

Apr 14, 2025
pulisher
Apr 14, 2025

Class Action Filed Against Intellia Therapeutics, Inc. (NTLA)April 14, 2025 Deadline to JoinContact Levi & Korsinsky - ACCESS Newswire

Apr 14, 2025
pulisher
Apr 14, 2025

FINAL DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - Business Wire

Apr 14, 2025
pulisher
Apr 14, 2025

FINAL REMINDER NTLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Alerts Intellia Therapeutics, Inc. Investors to Participate in the Class Action Lawsuit - markets.businessinsider.com

Apr 14, 2025
pulisher
Apr 14, 2025

NTLA Investors are Reminded of the Final Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit with the Schall Law Firm - The Malaysian Reserve

Apr 14, 2025
pulisher
Apr 14, 2025

NTLA Lawsuit Alert! Class Action Lawsuit Against Intellia Therapeutics Inc. - TipRanks

Apr 14, 2025
pulisher
Apr 13, 2025

Intellia Therapeutics, Inc. Sued for Securities Law ViolationsContact Levi & Korsinsky Before April 14, 2025 to Discuss Your RightsNTLA - PR Newswire

Apr 13, 2025
pulisher
Apr 13, 2025

NTLA Deadline: NTLA Investors Have Opportunity to Lead Intellia Therapeutics, Inc. Securities Fraud Lawsuit - Morningstar

Apr 13, 2025
pulisher
Apr 13, 2025

FINAL NTLA DEADLINE: Bronstein, Gewirtz & Grossman LLC Reminds Intellia Therapeutics, Inc. Investors to Join the Class Action Lawsuit - markets.businessinsider.com

Apr 13, 2025
pulisher
Apr 13, 2025

NTLA Investors Have the Opportunity to Lead the Intellia - GlobeNewswire

Apr 13, 2025
pulisher
Apr 13, 2025

NTLA Investors Have the Opportunity to Lead the Intellia Therapeutics Securities Fraud Lawsuit with Faruqi & Faruqi, LLP - Morningstar

Apr 13, 2025
pulisher
Apr 12, 2025

NTLA DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. - Bluefield Daily Telegraph

Apr 12, 2025
pulisher
Apr 12, 2025

NTLA DEADLINE ALERT: ROSEN, RECOGNIZED INVESTOR COUNSEL, - GlobeNewswire

Apr 12, 2025
pulisher
Apr 12, 2025

התראת מועד אחרון לתביעה נגד NTLA: רוזן, למשקיעים מוכר, מעודד את משקיעי Intellia Therapeutics, Inc עם הפסדים העולים על 100 אלף דולר, להבטיח ייעוץ לפני המועד האחרון החשוב של 14 באפריל בתביעה ייצוגית בניירות ערך – NTLA - GlobeNewswire Inc.

Apr 12, 2025
pulisher
Apr 11, 2025

Intellia Therapeutics, Inc. Investors: Please contact the - GlobeNewswire

Apr 11, 2025
pulisher
Apr 11, 2025

NTLA Deadline: Rosen Law Firm Urges Intellia Therapeutics, Inc. (NASDAQ: NTLA) Stockholders with Losses in Excess of $50K to Contact the Firm for Information About Their Rights - Eagle-Tribune

Apr 11, 2025
pulisher
Apr 10, 2025

SHAREHOLDER REMINDER: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - PR Newswire

Apr 10, 2025
pulisher
Apr 10, 2025

NTLA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Stockholders of Intellia Therapeutics, Inc. to Contact the Firm Today! - markets.businessinsider.com

Apr 10, 2025
pulisher
Apr 10, 2025

The Gross Law Firm Notifies Intellia Therapeutics, Inc. Investors of a Class Action Lawsuit and Upcoming DeadlineNTLA - PR Newswire

Apr 10, 2025
pulisher
Apr 09, 2025

NTLA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

NTLA DEADLINE: ROSEN, TOP-RANKED INVESTOR COUNSEL, Encourages Intellia Therapeutics, Inc. - Bluefield Daily Telegraph

Apr 09, 2025
pulisher
Apr 09, 2025

Lost Money on Intellia Therapeutics, Inc. (NTLA)? Join - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

Lost Money on Intellia Therapeutics, Inc. (NTLA)? Join Class Action Suit Seeking Recovery – ... - Bluefield Daily Telegraph

Apr 09, 2025
pulisher
Apr 09, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP - GlobeNewswire

Apr 09, 2025
pulisher
Apr 09, 2025

INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - Morningstar

Apr 09, 2025
pulisher
Apr 09, 2025

Intellia Therapeutics, Inc. (NTLA): Among Stocks Under $10 that Will Triple - Insider Monkey

Apr 09, 2025
pulisher
Apr 09, 2025

Vanguard Group Inc. Has $118.82 Million Position in Intellia Therapeutics, Inc. (NASDAQ:NTLA) - Defense World

Apr 09, 2025
pulisher
Apr 08, 2025

Intellia Therapeutics, Inc. (NASDAQ: NTLA) Investor Alert: Deadline in Lawsuit on April 14, 2025 - openPR.com

Apr 08, 2025
pulisher
Apr 08, 2025

NTLA INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Reminds Investors of Intellia Therapeutics, Inc. to Contact the Firm Today! - markets.businessinsider.com

Apr 08, 2025
pulisher
Apr 08, 2025

Class Action Filed Against Intellia Therapeutics, Inc. (NTLA) Seeking Recovery for InvestorsContact Levi & Korsinsky - Morningstar

Apr 08, 2025
pulisher
Apr 07, 2025

DEADLINE ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Intellia Therapeutics - StreetInsider

Apr 07, 2025
$20.59
price up icon 0.24%
$69.69
price up icon 1.06%
$32.20
price up icon 0.53%
$23.46
price down icon 36.06%
$102.02
price down icon 15.36%
biotechnology ONC
$244.90
price down icon 4.40%
자본화:     |  볼륨(24시간):